These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28397249)

  • 1. Safety issues of compounds acting on adenosinergic signalling.
    Schmidt J; Ferk P
    J Pharm Pharmacol; 2017 Jul; 69(7):790-806. PubMed ID: 28397249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological modulation of adenosine receptor pathways and inflammatory disorders: the way towards novel therapeutics?
    Antonioli L; Fornai M; Colucci R; Tuccori M; Blandizzi C
    Expert Opin Investig Drugs; 2011 Jun; 20(6):717-21. PubMed ID: 21506907
    [No Abstract]   [Full Text] [Related]  

  • 3. Therapeutic potency of pharmacological adenosine receptor agonist/antagonist in angiogenesis, current status and perspectives.
    Bahreyni A; Khazaei M; Rajabian M; Ryzhikov M; Avan A; Hassanian SM
    J Pharm Pharmacol; 2018 Feb; 70(2):191-196. PubMed ID: 29057476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenosine receptor desensitization and trafficking.
    Mundell S; Kelly E
    Biochim Biophys Acta; 2011 May; 1808(5):1319-28. PubMed ID: 20550943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expeditious synthesis and biological evaluation of new C-6 1,2,3-triazole adenosine derivatives A1 receptor antagonists or agonists.
    Mathew SC; By Y; Berthault A; Virolleaud MA; Carrega L; Chouraqui G; Commeiras L; Condo J; Attolini M; Gaudel-Siri A; Ruf J; Rodriguez J; Parrain JL; Guieu R
    Org Biomol Chem; 2010 Sep; 8(17):3874-81. PubMed ID: 20617271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Adenosinergic System in Diabetic Retinopathy.
    Vindeirinho J; Santiago AR; Cavadas C; Ambrósio AF; Santos PF
    J Diabetes Res; 2016; 2016():4270301. PubMed ID: 27034960
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular adenosine receptors; potential clinical applications.
    Ho MF; Rose'Meyer RB
    Curr Vasc Pharmacol; 2013 May; 11(3):327-37. PubMed ID: 22724462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keep an eye on adenosine: Its role in retinal inflammation.
    Santiago AR; Madeira MH; Boia R; Aires ID; Rodrigues-Neves AC; Santos PF; Ambrósio AF
    Pharmacol Ther; 2020 Jun; 210():107513. PubMed ID: 32109489
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newer targets for modulation of intraocular pressure: focus on adenosine receptor signaling pathways.
    Agarwal R; Agarwal P
    Expert Opin Ther Targets; 2014 May; 18(5):527-39. PubMed ID: 24579961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in the Development of Agonists, Antagonists and Allosteric Modulators of Adenosine Receptors.
    Deb PK
    Curr Pharm Des; 2019; 25(25):2695-2696. PubMed ID: 31603053
    [No Abstract]   [Full Text] [Related]  

  • 11. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells.
    Costa MA; Barbosa A; Neto E; Sá-e-Sousa A; Freitas R; Neves JM; Magalhães-Cardoso T; Ferreirinha F; Correia-de-Sá P
    J Cell Physiol; 2011 May; 226(5):1353-66. PubMed ID: 20945394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine receptor ligands-recent developments part I. Agonists.
    Muller CE
    Curr Med Chem; 2000 Dec; 7(12):1269-88. PubMed ID: 11032971
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contractile effects and receptor analysis of adenosine-receptors in human detrusor muscle from stable and neuropathic bladders.
    Pakzad M; Ikeda Y; McCarthy C; Kitney DG; Jabr RI; Fry CH
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Aug; 389(8):921-9. PubMed ID: 27185496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purinergic signalling in brain ischemia.
    Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
    Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Adenosinergic System as a Therapeutic Target in the Vasculature: New Ligands and Challenges.
    Sousa JB; Diniz C
    Molecules; 2017 May; 22(5):. PubMed ID: 28481238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of adenosine receptors in ischemia-reperfusion injury.
    Laubach VE; French BA; Okusa MD
    Expert Opin Ther Targets; 2011 Jan; 15(1):103-18. PubMed ID: 21110787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. P1 (adenosine) purinoceptor assays.
    Mustafa SJ; Ansari HR; Abebe W
    Curr Protoc Pharmacol; 2009 Jun; Chapter 4():Unit 4.7. PubMed ID: 22294395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of adenosinergic pathway in human autoimmune diseases.
    Dong K; Gao ZW; Zhang HZ
    Immunol Res; 2016 Dec; 64(5-6):1133-1141. PubMed ID: 27665459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beneficial and detrimental role of adenosine signaling in diseases and therapy.
    Liu H; Xia Y
    J Appl Physiol (1985); 2015 Nov; 119(10):1173-82. PubMed ID: 26316513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine receptors as drug targets--what are the challenges?
    Chen JF; Eltzschig HK; Fredholm BB
    Nat Rev Drug Discov; 2013 Apr; 12(4):265-86. PubMed ID: 23535933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.